The CDF detector: an overview
F Abe, D Amidei, G Apollinari, G Ascoli, M Atac… - Nuclear Instruments and …, 1988 - Elsevier
The Collider Detector at Fermilab (CDF) is a 5000 t magnetic detector built to study 2 TeV p
p collisions at the Fermilab Tevatron. Event analysis is based on charged particle tracking, …
p collisions at the Fermilab Tevatron. Event analysis is based on charged particle tracking, …
[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms
…, KN Naresh, Y Natkunam, SB Ng, I Oschlies, G Ott… - Leukemia, 2022 - nature.com
We herein present an overview of the upcoming 5 th edition of the World Health Organization
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …
Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid …
[HTML][HTML] The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms
… Cytopenia definitions are harmonized for CCUS, MDS, and MDS/MPN; they include Hb <13
g/dL in males and <12 g/dL in females for anaemia, absolute neutrophil count <1.8 ×10 9 /L …
g/dL in males and <12 g/dL in females for anaemia, absolute neutrophil count <1.8 ×10 9 /L …
[HTML][HTML] The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
…, TM Grogan, TP Miller, M LeBlanc, G Ott… - … England Journal of …, 2002 - Mass Medical Soc
Background The survival of patients with diffuse large-B-cell lymphoma after chemotherapy
is influenced by molecular features of the tumors. We used the gene-expression profiles of …
is influenced by molecular features of the tumors. We used the gene-expression profiles of …
[HTML][HTML] Stromal gene signatures in large-B-cell lymphomas
G Lenz, G Wright, SS Dave, W Xiao… - … England Journal of …, 2008 - Mass Medical Soc
Background The addition of rituximab to combination chemotherapy with cyclophosphamide,
doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved …
doxorubicin, vincristine, and prednisone (CHOP), or R-CHOP, has significantly improved …
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
…, J Powell, J Jiang, CJ Thomas, A Rosenwald, G Ott… - Nature, 2010 - nature.com
… Lysates were cleared by centrifugation at 15,000g at 4 C for 10 min, and protein concentrations
were determined by bicinchoninic acid protein assay (Pierce). Lysates (80–100 μg) were …
were determined by bicinchoninic acid protein assay (Pierce). Lysates (80–100 μg) were …
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
…, TR Golub, R Beroukhim, GG Wulf, G Ott… - Nature medicine, 2018 - nature.com
Diffuse large B cell lymphoma (DLBCL), the most common lymphoid malignancy in adults,
is a clinically and genetically heterogeneous disease that is further classified into …
is a clinically and genetically heterogeneous disease that is further classified into …
[HTML][HTML] Genetics and pathogenesis of diffuse large B-cell lymphoma
…, A Lopez-Guillermo, A Rosenwald, G Ott… - New England journal …, 2018 - Mass Medical Soc
Background Diffuse large B-cell lymphomas (DLBCLs) are phenotypically and genetically
heterogeneous. Gene-expression profiling has identified subgroups of DLBCL (activated B-cell…
heterogeneous. Gene-expression profiling has identified subgroups of DLBCL (activated B-cell…
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
…, TC Greiner, RD Gascoyne, J Delabie, G Ott… - Blood, 2004 - ashpublications.org
Diffuse large B-cell lymphoma (DLBCL) can be divided into prognostically important
subgroups with germinal center B-cell–like (GCB), activated B-cell–like (ABC), and type 3 gene …
subgroups with germinal center B-cell–like (GCB), activated B-cell–like (ABC), and type 3 gene …
Oncogenically active MYD88 mutations in human lymphoma
…, J Powell, A Rosenwald, HK Muller-Hermelink, G Ott… - Nature, 2011 - nature.com
… Lysates were cleared by centrifuging for 20 min at 14,000g at 4 C. MYD88–GFP constructs
were immunoprecipitated with washed anti-GFP agarose beads (Chromotek) for 30 min at 4 C…
were immunoprecipitated with washed anti-GFP agarose beads (Chromotek) for 30 min at 4 C…